Palvella Therapeutics, Inc. PVLA
175.92 USD +19.07 (+12.16%)
At closeNov 6, 2026, 4:00 PM EST
175.92 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
156.54 Day range 176.60
72.23 52-week range 176.94
- YTD
- +68.07%
- 1 year
- +123.73%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -38.60M | -14.10M | -11.87M | -43.47M | -51.83M | |
| -41.72M | -17.43M | 18.69M | -33.28M | -45.74M | |
| -3.71 | -7.83 | 2.17 | -36.00 | -57.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 57.98M | 83.60M | 7.35M | 38.63M | 117.76M | |
| 59.56M | 88.23M | 7.55M | 95.49M | 153.56M | |
| 31.58M | 25.63M | 11.43M | 67.56M | 102.81M | |
| 633.00K | 0 | 0 | 13.10M | 13.84M | |
| 27.98M | 62.61M | -74.48M | 27.93M | 50.76M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -25.01M | -10.84M | -13.70M | -59.93M | -7.66M | |
| -660.00K | 87.09M | 5.00M | 7.21M | 59.13M | |
| -25.62M | 76.25M | -8.70M | -79.13M | 47.33M |